Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction
Copyright © 2022 Elsevier Inc. All rights reserved..
We aimed to describe the SARS-CoV-2 lineages circulating early pandemic among samples with S gene dropout and characterize the receptor-binding domain (RBD) of viral spike protein. Adults and children older than 2 months with signs and symptoms of COVID-19 were prospectively enrolled from May to October in Porto Alegre, Brazil. All participants performed RT-PCR assay, and samples with S gene dropout and cycle threshold < 30 were submitted to high-throughput sequencing (HTS). 484 out of 1,557 participants tested positive for SARS-CoV-2. The S gene dropout was detected in 7.4% (36/484) and a peak was observed in August. The B.1.1.28, B.1.91 and B.1.1.33 lineages were circulating in early pandemic. The RBD novel mutation (Y380Q) was found in one sample occurring simultaneously with C379W and V395A, and the B.1.91 lineage in the spike protein. The Y380Q and C379W may interfere with the binding of neutralizing antibodies (CR3022, EY6A, H014, S304).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:102 |
|---|---|
| Enthalten in: |
Diagnostic microbiology and infectious disease - 102(2022), 4 vom: 20. Apr., Seite 115636 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sartor, Ivaine Tais Sauthier [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 22.03.2022 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.diagmicrobio.2022.115636 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337510261 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337510261 | ||
| 003 | DE-627 | ||
| 005 | 20231225234555.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.diagmicrobio.2022.115636 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1124.xml |
| 035 | |a (DE-627)NLM337510261 | ||
| 035 | |a (NLM)35219552 | ||
| 035 | |a (PII)S0732-8893(22)00004-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sartor, Ivaine Tais Sauthier |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2022 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
| 520 | |a We aimed to describe the SARS-CoV-2 lineages circulating early pandemic among samples with S gene dropout and characterize the receptor-binding domain (RBD) of viral spike protein. Adults and children older than 2 months with signs and symptoms of COVID-19 were prospectively enrolled from May to October in Porto Alegre, Brazil. All participants performed RT-PCR assay, and samples with S gene dropout and cycle threshold < 30 were submitted to high-throughput sequencing (HTS). 484 out of 1,557 participants tested positive for SARS-CoV-2. The S gene dropout was detected in 7.4% (36/484) and a peak was observed in August. The B.1.1.28, B.1.91 and B.1.1.33 lineages were circulating in early pandemic. The RBD novel mutation (Y380Q) was found in one sample occurring simultaneously with C379W and V395A, and the B.1.91 lineage in the spike protein. The Y380Q and C379W may interfere with the binding of neutralizing antibodies (CR3022, EY6A, H014, S304) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Novel mutation | |
| 650 | 4 | |a RBD | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Variants | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a CR3022 |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 700 | 1 | |a Varela, Fernanda Hammes |e verfasserin |4 aut | |
| 700 | 1 | |a Meireles, Mariana Rost |e verfasserin |4 aut | |
| 700 | 1 | |a Kern, Luciane Beatriz |e verfasserin |4 aut | |
| 700 | 1 | |a Azevedo, Thaís Raupp |e verfasserin |4 aut | |
| 700 | 1 | |a Giannini, Gabriela Luchiari Tumioto |e verfasserin |4 aut | |
| 700 | 1 | |a da Silva, Mariana Soares |e verfasserin |4 aut | |
| 700 | 1 | |a Demoliner, Meriane |e verfasserin |4 aut | |
| 700 | 1 | |a Gularte, Juliana Schons |e verfasserin |4 aut | |
| 700 | 1 | |a de Almeida, Paula Rodrigues |e verfasserin |4 aut | |
| 700 | 1 | |a Fleck, Juliane Deise |e verfasserin |4 aut | |
| 700 | 1 | |a Zavaglia, Gabriela Oliveira |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandes, Ingrid Rodrigues |e verfasserin |4 aut | |
| 700 | 1 | |a de David, Caroline Nespolo |e verfasserin |4 aut | |
| 700 | 1 | |a Santos, Amanda Paz |e verfasserin |4 aut | |
| 700 | 1 | |a de Almeida, Walquiria Aparecida Ferreira |e verfasserin |4 aut | |
| 700 | 1 | |a Porto, Victor Bertollo Gomes |e verfasserin |4 aut | |
| 700 | 1 | |a Scotta, Marcelo Comerlato |e verfasserin |4 aut | |
| 700 | 1 | |a Vieira, Gustavo Fioravanti |e verfasserin |4 aut | |
| 700 | 1 | |a Spilki, Fernando Rosado |e verfasserin |4 aut | |
| 700 | 1 | |a Stein, Renato T |e verfasserin |4 aut | |
| 700 | 1 | |a Polese-Bonatto, Márcia |e verfasserin |4 aut | |
| 700 | 0 | |a COVIDa study group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diagnostic microbiology and infectious disease |d 1986 |g 102(2022), 4 vom: 20. Apr., Seite 115636 |w (DE-627)NLM01262845X |x 1879-0070 |7 nnns |
| 773 | 1 | 8 | |g volume:102 |g year:2022 |g number:4 |g day:20 |g month:04 |g pages:115636 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diagmicrobio.2022.115636 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 102 |j 2022 |e 4 |b 20 |c 04 |h 115636 | ||